Sivik Global Healthcare LLC / JNJ
Sivik Global Healthcare LLC’s Johnson & Johnson Position
Does Sivik Global Healthcare LLC own Johnson & Johnson (JNJ)? Yes — 20.0K shares worth $5M (+3.71% of its 13F portfolio) as of Q1 2026, down from 25.0K shares the prior filed quarter.
Position Value
$5M
Q1 2026
Shares
20.0K
% of Portfolio
+3.71%
Quarters Held
14
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 20.0K | $5M | +3.71% |
| Q3 2025 | 25.0K | $5M | +1.35% |
| Q4 2022 | 15.0K | $3M | +1.25% |
| Q3 2022 | 37.5K | $6M | +3.40% |
| Q2 2022 | 25.0K | $4M | +2.52% |
| Q1 2022 | 35.0K | $6M | +2.56% |
| Q4 2021 | 30.0K | $5M | +2.20% |
| Q3 2021 | 70.0K | $11M | +2.70% |
| Q2 2021 | 55.0K | $9M | +1.77% |
| Q1 2021 | 35.0K | $6M | +2.10% |
| Q4 2020 | 65.0K | $10M | +4.17% |
| Q3 2020 | 60.0K | $9M | +3.84% |
| Q2 2020 | 30.0K | $4M | +1.40% |
| Q4 2019 | 35.0K | $5M | +1.89% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sivik Global Healthcare LLC’s full portfolio or all institutional holders of JNJ.